Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictors of response to venetoclax and therapeutic potential of CDK7 inhibition in multiple myeloma.
Dutta RP, Thibaud S, Leshchenko V, Ram M, Melnekoff DT, Bhalla S, Restrepo P, Gupta VA, Barwick BG, Newman S, McCafferty J, Hantash F, Nooka AK, Cho HJ, Richard S, Rodriguez C, Rossi A, Sanchez L, Chari A, Boise LH, Jagannath S, Richter J, Parekh S, Laganà A. Dutta RP, et al. Among authors: nooka ak. Blood Neoplasia. 2024 Oct 14;1(4):100049. doi: 10.1016/j.bneo.2024.100049. eCollection 2024 Dec. Blood Neoplasia. 2024. PMID: 40552134 Free PMC article.
Feasibility and Safety of Outpatient Model for Administration of Bispecific Antibodies: Proceedings from an International Myeloma Society 21st Annual Meeting Oral Abstract.
Scott SA, Roberts DL, Gupta VA, Joseph NS, Hofmeister CC, Dhodapkar MV, Lonial S, Nooka AK, Kaufman JL. Scott SA, et al. Among authors: nooka ak. Clin Lymphoma Myeloma Leuk. 2025 Apr 8:S2152-2650(25)00127-2. doi: 10.1016/j.clml.2025.04.002. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40345961 Free article.
Stem Cell Mobilization Yields with Daratumumab (Dara) and Lenalidomide (Len)-Containing Quadruplet Induction Therapy in Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Real-World Experience at 2 Institutes.
Varga C, Robinson M, Gupta V, Hofmeister CC, Nooka AK, Kaufman JL, Dhodapkar MV, Lonial S, Borden S, Ferreri C, Paul B, Atrash S, Bhutani M, Voorhees PM, Joseph NS. Varga C, et al. Among authors: nooka ak. Clin Lymphoma Myeloma Leuk. 2025 Apr 11:S2152-2650(25)00126-0. doi: 10.1016/j.clml.2025.04.003. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40340128
Expert Perspectives on Current Challenges and Emerging Approaches for Multiple Myeloma: Narrative Review of an Inaugural Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma.
Chari A, Bal S, Ailawadhi S, Krishnan A, Patel KK, Berdeja JG, Garfall A, Callander N, Banerjee R, Alsina M, Nooka AK, Dhakal B, Gasparetto C, Costello C. Chari A, et al. Among authors: nooka ak. Clin Lymphoma Myeloma Leuk. 2025 Mar 11:S2152-2650(25)00098-9. doi: 10.1016/j.clml.2025.03.008. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2025. PMID: 40175263
Belantamab Mafodotin Plus Proteasome Inhibition Efficacy Versus Comparators in Early Relapsed Myeloma: A Systematic Review and Network Meta-Analysis.
Richter J, Nooka A, Rodríguez-Otero P, Schjesvold F, Katodritou E, Combe E, Scott M, Cooper L, Sly I, Ballew N, Bitetti J, Boytsov N, Purser M, McNamara S. Richter J, et al. Among authors: nooka a. Am J Hematol. 2025 Jun;100(6):998-1009. doi: 10.1002/ajh.27661. Epub 2025 Mar 27. Am J Hematol. 2025. PMID: 40143674 Free PMC article.
Impact of COVID-19 on outcomes with teclistamab in patients with relapsed/refractory multiple myeloma in the phase 1/2 MajesTEC-1 study.
van de Donk NWCJ, Bahlis N, Costa LJ, Mateos MV, Nooka AK, Perrot A, Garfall AL, Thaman P, Qi K, Uhlar C, Chastain K, Doyle M, Usmani SZ. van de Donk NWCJ, et al. Among authors: nooka ak. Blood Cancer J. 2024 Oct 21;14(1):186. doi: 10.1038/s41408-024-01160-1. Blood Cancer J. 2024. PMID: 39433732 Free PMC article. No abstract available.
201 results